BRIEF published on 12/18/2025 at 22:10, 1 month 18 days ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 1 month 18 days ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
BRIEF published on 12/18/2025 at 22:10, 1 month 18 days ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
PRESS RELEASE published on 12/18/2025 at 22:05, 1 month 18 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 1 month 18 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 1 month 18 days ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
BRIEF published on 12/17/2025 at 22:10, 1 month 19 days ago Abivax: 22 Abstracts on Obefazimod Presented at ECCO 2026 Abivax Obefazimod Efficiency Fibrosis IBD
BRIEF published on 12/17/2025 at 22:10, 1 month 19 days ago Abivax : 22 Abstracts sur Obefazimod Présentés à l'ECCO 2026 Abivax Obefazimod Efficacité Fibrose MICI
BRIEF published on 12/17/2025 at 22:10, 1 month 19 days ago Abivax Unveils New Data on Obefazimod at ECCO 2026 Abivax Obefazimod Ulcerative Colitis ECCO 2026 Anti-fibrotic
BRIEF published on 12/17/2025 at 22:10, 1 month 19 days ago Abivax dévoile de nouvelles données sur l'obefazimod à l'ECCO 2026 Abivax Obefazimod Rectocolite Hémorragique ECCO 2026 Antifibrotique
Published on 02/06/2026 at 03:50, 1 hour 7 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 2 hours 12 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 4 hours ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 4 hours 57 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 5 hours 42 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 19:27, 9 hours 30 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 10 hours 11 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 10 hours 48 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 11 hours 2 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 11 hours 17 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 19:15, 9 hours 42 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 9 hours 42 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 9 hours 42 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
